PharmaBlock Sciences (Nanjing), Inc.

  • Market Cap: Mid Cap
  • Industry: Miscellaneous
  • ISIN: CNE1000035K5
CNY
34.36
-1.05 (-2.97%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

With ROE of 5.33%, it has a fair valuation with a 2.62 Price to Book Value

  • Over the past year, while the stock has generated a return of -8.69%, its profits have risen by 23.2% ; the PEG ratio of the company is 2.1
  • At the current price, the company has a high dividend yield of 0.5
stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Miscellaneous

stock-summary
Market cap

CNY 7,711 Million (Mid Cap)

stock-summary
P/E

49.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.61%

stock-summary
Debt Equity

-0.10

stock-summary
Return on Equity

2.82%

stock-summary
Price to Book

1.08

Revenue and Profits:
Net Sales:
499 Million
(Quarterly Results - Sep 2025)
Net Profit:
41 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.47%
0%
-10.47%
6 Months
-15.33%
0%
-15.33%
1 Year
-5.21%
0%
-5.21%
2 Years
-13.54%
0%
-13.54%
3 Years
-53.95%
0%
-53.95%
4 Years
-65.78%
0%
-65.78%
5 Years
-70.93%
0%
-70.93%

PharmaBlock Sciences (Nanjing), Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
16.48%
EBIT Growth (5y)
-0.18%
EBIT to Interest (avg)
36.57
Debt to EBITDA (avg)
1.36
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.36
Tax Ratio
10.97%
Dividend Payout Ratio
25.37%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
12.85%
ROE (avg)
11.32%

Valuation key factors

Factor
Value
P/E Ratio
49
Industry P/E
Price to Book Value
2.62
EV to EBIT
44.86
EV to EBITDA
26.83
EV to Capital Employed
2.72
EV to Sales
5.05
PEG Ratio
2.12
Dividend Yield
0.50%
ROCE (Latest)
6.07%
ROE (Latest)
5.33%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 7.45% vs 2.13% in Jun 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Sep 2025 is 11.44% vs 2.51% in Jun 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Jun'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "499.30",
          "val2": "464.70",
          "chgp": "7.45%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.50",
          "val2": "77.50",
          "chgp": "-58.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "9.90",
          "val2": "13.00",
          "chgp": "-23.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "2.30",
          "val2": "0.70",
          "chgp": "228.57%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "40.90",
          "val2": "36.70",
          "chgp": "11.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "65.10%",
          "val2": "92.00%",
          "chgp": "-2.69%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -2.22% vs 8.61% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.20% vs -39.43% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,680.80",
          "val2": "1,719.00",
          "chgp": "-2.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "357.10",
          "val2": "380.80",
          "chgp": "-6.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "62.30",
          "val2": "68.20",
          "chgp": "-8.65%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "8.00",
          "val2": "-32.70",
          "chgp": "124.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "219.50",
          "val2": "197.40",
          "chgp": "11.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "129.70%",
          "val2": "150.80%",
          "chgp": "-2.11%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQstock-summary

Sep'25
Jun'25
Change(%)
Net Sales
499.30
464.70
7.45%
Operating Profit (PBDIT) excl Other Income
32.50
77.50
-58.06%
Interest
9.90
13.00
-23.85%
Exceptional Items
2.30
0.70
228.57%
Consolidate Net Profit
40.90
36.70
11.44%
Operating Profit Margin (Excl OI)
65.10%
92.00%
-2.69%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Sep 2025 is 7.45% vs 2.13% in Jun 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Sep 2025 is 11.44% vs 2.51% in Jun 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
1,680.80
1,719.00
-2.22%
Operating Profit (PBDIT) excl Other Income
357.10
380.80
-6.22%
Interest
62.30
68.20
-8.65%
Exceptional Items
8.00
-32.70
124.46%
Consolidate Net Profit
219.50
197.40
11.20%
Operating Profit Margin (Excl OI)
129.70%
150.80%
-2.11%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -2.22% vs 8.61% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.20% vs -39.43% in Dec 2023

stock-summaryCompany CV
About PharmaBlock Sciences (Nanjing), Inc. stock-summary
stock-summary
PharmaBlock Sciences (Nanjing), Inc.
Miscellaneous
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available